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ABSTRACT
Bacterial infections that can no longer be treated by antibiotics because of bacterial
mutations cause many infections and deaths each year. My research conducted aims to
study how membrane fatty acid composition can affect bacterial susceptibility to
antibiotics. Listeria monocytogenes, a gram-positive facultative anaerobe, is the
bacterium that I am testing. Listeria has 80-90% branched-chain fatty acids (BCFAs)
which allow membrane fluidity and sufficient protection against invaders. When Listeria
is grown in the presence of butyrate, the BCFAs become straight-chain fatty acids
(SCFAs) and make the once fluid membrane more rigid. We believe that this allows for
easier antibiotic penetration of the phospholipid bilayer which lets the antibiotics affect
cellular processes. By changing concentrations of butyrate I can therefore determine the
minimum inhibitory concentrations of antibiotics for Listeria with different membrane fatty
acid compositions. Moreover, as growth is a key factor in bacterial susceptibility to
antibiotics. I also measure oxygen consumption rate in response to butyrate. Higher
oxygen consumption rate is indicative of higher bacterial activity. Because oxygen
consumption is carried out by protein complexes on the membrane, measuring oxygen
consumption rate also reveal the effects of butyrate on cell membrane functionality.

RESULTS

RESULTS

The average optical density of Listeria across various concentrations of two different antibiotics. *not statistically significant*

Preliminary data on the oxygen consumption rate of aerobically and anaerobically grown bacteria

MATERIALS AND METHODS
Oxygen Consumption Measurement
Suspensions of bacteria grown under different conditions were prepared and used for
oxygen consumption measurement. A oxygen concentration probe was used to monitor
oxygen consumption inside an anaerobic chamber where a no bacteria control sample
was included to measure abiotic loss of oxygen.

Ratio of aerobically-grown bacteria supplemented with butyrate compared to
aerobically-grown bacteria with no butyrate supplementation. No butyrate
supplementation is the baseline (1). Any bar lower than 1 means a lower oxygen
consumption rate.

Ratio of anaerobically-grown bacteria supplemented with butyrate compared to
anaerobically-grown bacteria with no butyrate supplementation. No butyrate
supplementation is the baseline (1). Any bar lower than 1 means a lower oxygen
consumption rate.

Transmission Electron Microscopy (TEM)
Bacterial were grown in BHI with or without 100mM butyrate for TEM analysis. To
prepare the bacterial samples for TEM, the SPI Chem SPI-Pon 812 Kit protocol was used
to suspend the two different types of bacteria in resin with each type of bacteria in a
separate resin. The dried samples were then cut into 100 nm sections using an ultramicrotome with a diamond blade. The sections were imaged on carbon grids by a Hitachi
H-7600 Transmission Electron Microscope at 100kv and at varying magnifications
between 3,000 and 80,000 x.
Antibiotic Susceptibility Assay
The final experimental procedure investigated that efficacy of eight different antibiotics
on Listeria grown with and without 100 mM of butyrate. The eight antibiotics tested were
chloramphenicol, erythromycin, neomycin, kanamycin sulfate, penicillin, moxalactam,
streptomycin sulfate, and lysozyme. Chloramphenicol and erythromycin were only soluble
in ethanol, while the other six antibiotics were soluble in water. Penicillin and moxalactam
target bacterial cell wall synthesis outside the bacterial cells, while the other six antibiotics
target pathways inside the bacterial cells. Each antibiotic was serially diluted and added to
bacterial cultures inside sterile 96-well plates with or without butyrate supplementation.
The final concentration of antibiotics increased every three wells from 8 µg/ml, 16 µg/ml, to
32 µg/ml, 64 µg/ml, 128 µg/ml, 256 µg/ml, and finally 512 µg/ml. The plates were then
incubated and grown overnight aerobically at 37°C. The optical density of both types of
bacteria were taken before the experiment and subtracted off the final value.
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The average optical density of Listeria across various concentrations of penicillin. *statistically
significant*

MAIN FINDINGS
The average optical density of the butyrate-supplemented Listeria was lower than the
Listeria with no butyrate at every concentration tested. Additionally, the average rate of
change between the beginning optical density and the final optical density, as well as the
average rate of change between each concentration were both lower in the bacteria that was
grown with butyrate. My thesis research identified that butyrate supplementation, which
is known to increase the amount of straight chain fatty acids in Listeria, lowers the
oxygen consumption rate of Listeria monocytogenes, with the largest decrease in
oxygen consumption rate at a butyrate concentration of 100 mM. Moreover, butyrate
supplementation also resulted in an altered morphology as well as increased
susceptibility to penicillin.

Listeria monocytogenes without butyrate supplementation

Listeria monocytogenes with 100 mM butyrate supplementation
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FUTURE RESEARCH
This research can be used by the pharmaceutical industry in an effort to combat the
issue of antibiotic resistant bacteria in the United States and the rest of the world. Instead of
increasing the dosage of antibiotics prescribed or spending billions of dollars to develop new
and unique antibiotics, the pharmaceutical industry could use this research to investigate how
changing the composition of the bacteria can increase the efficacy of antibiotics. Further
research in this field is necessary in order to confirm these findings. Further research should
investigate the effects of butyrate on other types of bacteria, other types of antibiotics, and
the effects of the supplementation of other short-chain fatty acids besides butyrate.

